US researchers say a deep-learning framework provides the most detailed picture yet of how utility-scale solar uses land, revealing unexpected efficiency gaps and clearer pathways for agrivoltaics and ...

TOKYO--(BUSINESS WIRE)--Mitsubishi Electric Corporation (TOKYO: 6503) announced today that it has developed the world’s first technology to generate millimeter-scale flow within a channel by using ...

The earlier the age a child received a smartphone the greater the health risk. Children who have smartphones by age 12 are at higher risk of lack of sleep, obesity and depression, according to a new ...

15 BTC treasury companies trading below NAV of their tokens Saylor's Strategy down almost 36% in November Nov 28 (Reuters) - Fresh turbulence in the crypto market is weighing on shares of companies ...

New research suggests that even slightly high blood pressure in your 30s may raise the risk of a heart attack or stroke later in life. The study by University College London (UCL) of more than 450 ...

Recall due to the presence of nitrosamine impurities, classified as potential carcinogens. HealthDay News — The US Food and Drug Administration (FDA) has recalled over half a million bottles of a ...

NEW YORK (PIX11) – Hundreds of thousands of blood pressure medication pills are being recalled across the United States, according to the Federal Drug Administration. Prazosin Hydrochloride (brand ...

More than a half-million bottles of Prazosin Hydrochloride, a widely-used blood pressure medication are being recalled over concerns it contains unsafe levels of a cancer-causing chemical, with the ...

Check your medicine cabinet. A major pharmaceutical company has just recalled nearly 600,000 bottles of a blood pressure medication due to the presence of a potentially cancer-causing chemical.

More than half a million bottles of blood pressure medication are being recalled over a cancer-causing chemical connected to the prescription drug, according to the U.S. Food and Drug Administration.

The five-year clinical trial is the first of its kind in the United States to test whether showing patients their genetic risk for high blood pressure can lead to better blood pressure control, ...

High blood pressure, or hypertension, was the most common culprit, affecting over 95% of patients in South Korea and more than 93% in the U.S. Even in women under 60—the group often assumed to be at ...